Key result
A computational model predicted similar minimum durations of cryoballoon ablation to achieve transmural cellular nonviability across various cardiac thicknesses for AFA and AFA Pro cryoballoons.
Why the study?
Studies have used periprocedural parameters to optimize cryoballoon dosing, but the ablation durations required for transmural pulmonary vein isolation at varied tissue depths needed prediction.
A computational model predicts the minimum duration of cryoballoon ablation required to achieve transmural lesions based on acute time-to-isolation, which may help guide dosing strategies.
Supports device-specific cryoballoon dosing; extends TTI-based optimization to modeled transmural depths.
Background Preclinical and clinical studies have utilized periprocedural parameters to optimize cryoballoon ablation dosing, including acute time‐to‐isolation (TTI) of the pulmonary vein, balloon rate of freezing, balloon nadir temperature, and balloon‐thawing time. This study sought to predict the Arctic Front Advance (AFA) vs Arctic Front Advance Pro (AFA Pro) ablation durations required for transmural pulmonary vein isolation at varied tissue depths. Methods A cardiac‐specific, three‐dimensional computational model that incorporates structural characteristics, temperature‐dependent cellular responses, and thermal‐conductive properties was designed to predict the propagation of cold isotherms through tissue. The model assumed complete cryoballoon‐to‐pulmonary vein (PV) circumferential contact. Using known temperature thresholds of cardiac cellular electrical dormancy (at 23°C) and cellular nonviability (at −20°C), transmural time‐to‐isolation electrical dormancy (TTI ED ) and cellular nonviability (TTI NV ) were simulated. Results For cardiac thickness of 0.5, 1.25, 2.0, 3.0, 4.0, and 5.0 mm, the 23°C isotherm passed transmurally in 33, 38, 46, 62, 80, and 95 seconds during cryoablation utilizing AFA and 33, 38, 46, 63, 80, and 95 seconds with AFA Pro. Using the same cardiac thicknesses, the −20°C isotherm passed transmurally in 40, 55, 78, 161, 354, and 696 seconds during cryoablation with AFA and 40, 54, 78, 160, 352, and 722 seconds with AFA Pro. Conclusion This model predicted a minimum duration of cryoballoon ablation (TTI NV ) to obtain a transmural lesion when acute TTI of the PV was observed (TTI ED ). Consequently, the model is a useful tool for characterizing CBA dosing, which may guide future cryoablation dosing strategies.
No takes yet. Share an insight, caveat, or question.
Getman et al. (2019) studied Pulmonary vein isolation. Arctic Front Advance Pro (AFA Pro) cryoballoon vs. Arctic Front Advance (AFA) cryoballoon was evaluated on Transmural time-to-isolation electrical dormancy (TTI ED) and cellular nonviability (TTI NV). A computational model predicted similar minimum durations of cryoballoon ablation to achieve transmural cellular nonviability across various cardiac thicknesses for AFA and AFA Pro cryoballoons.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: